Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,000.60
+2.20 (0.22%)
Oct 23, 2026, 12:30 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 92.23 billion as of October 22, 2026. It is the 10,145th most valuable company in the world and the 606th biggest in India. Its market cap has increased by 23.45% in one year.
Market Cap
92.23B
Enterprise Value
108.18B
Revenue
50.04B
Global Rank
Country Rank
#606 India
PE Ratio
15.04
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 92.23B, an increase of 1,130.70%. That is a compound annual growth rate of 9.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 92.23B | 11.13% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 174.85B |
| Eris Lifesciences | 155.53B |
| Alivus Life Sciences | 153.79B |
| Alembic Pharmaceuticals | 153.12B |
| NATCO Pharma | 139.63B |
| Sudeep Pharma | 109.77B |
| Akums Drugs and Pharmaceuticals | 104.42B |
| Aarti Pharmalabs | 75.29B |